The efficacy and safety of Helicobacter pylori eradication therapy using vonopraza
Not Applicable
Completed
- Conditions
- Helicobacter pylori infection
- Registration Number
- JPRN-UMIN000021824
- Lead Sponsor
- Medical corporation Yamashita Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 800
Inclusion Criteria
Not provided
Exclusion Criteria
Past history of allergy for these medications, Vonoprazan, Amoxicillin, Clarithromycin, and Metronidazole used in this therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The rate of Helicobacter pylori eradication using 1st line triple therapy and 2nd line triple therapy
- Secondary Outcome Measures
Name Time Method The rate of side effects